143 related articles for article (PubMed ID: 11038156)
1. Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2.
Miranda CL; Yang YH; Henderson MC; Stevens JF; Santana-Rios G; Deinzer ML; Buhler DR
Drug Metab Dispos; 2000 Nov; 28(11):1297-302. PubMed ID: 11038156
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide supports human and rat cytochrome P450 1A2-catalyzed 2-amino-3-methylimidazo[4,5-f]quinoline bioactivation to mutagenic metabolites: significance of cytochrome P450 peroxygenase.
Anari MR; Josephy PD; Henry T; O'Brien PJ
Chem Res Toxicol; 1997 May; 10(5):582-8. PubMed ID: 9168257
[TBL] [Abstract][Full Text] [Related]
3. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
Edenharder R; Rauscher R; Platt KL
Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4, 5-f]quinoline.
Agus C; Ilett KF; Kadlubar FF; Minchin RF
Carcinogenesis; 2000 Jun; 21(6):1213-9. PubMed ID: 10837012
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts by indole-3-carbinol: dose-response studies in the rat colon.
Xu M; Schut HA; Bjeldanes LF; Williams DE; Bailey GS; Dashwood RH
Carcinogenesis; 1997 Nov; 18(11):2149-53. PubMed ID: 9395215
[TBL] [Abstract][Full Text] [Related]
6. Activation and effects of the food-derived heterocyclic amines in extrahepatic tissues.
Overvik E; Hellmold H; Branting C; Gustafsson JA
Princess Takamatsu Symp; 1995; 23():123-33. PubMed ID: 8844803
[TBL] [Abstract][Full Text] [Related]
7. Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Yanagawa Y; Sawada M; Deguchi T; Gonzalez FJ; Kamataki T
Cancer Res; 1994 Jul; 54(13):3422-7. PubMed ID: 8012961
[TBL] [Abstract][Full Text] [Related]
8. Identification of new 2-amino-3-methylimidazo[4,5-f]quinoline urinary metabolites from beta-naphthoflavone-treated mice.
Lakshmi VM; Hsu FF; Zenser TV
Drug Metab Dispos; 2009 Aug; 37(8):1690-7. PubMed ID: 19451400
[TBL] [Abstract][Full Text] [Related]
9. The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ).
Probst MR; Blum M; Fasshauer I; D'Orazio D; Meyer UA; Wild D
Carcinogenesis; 1992 Oct; 13(10):1713-7. PubMed ID: 1423830
[TBL] [Abstract][Full Text] [Related]
10. Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1.
Lautraite S; Musonda AC; Doehmer J; Edwards GO; Chipman JK
Mutagenesis; 2002 Jan; 17(1):45-53. PubMed ID: 11752233
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of beer on heterocyclic amine-induced mutagenesis and PhIP-induced aberrant crypt foci in rat colon.
Nozawa H; Tazumi K; Sato K; Yoshida A; Takata J; Arimoto-Kobayashi S; Kondo K
Mutat Res; 2004 Apr; 559(1-2):177-87. PubMed ID: 15066585
[TBL] [Abstract][Full Text] [Related]
12. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a Salmonella tester strain highly sensitive to mutagenic heterocyclic amines.
Suzuki A; Kushida H; Iwata H; Watanabe M; Nohmi T; Fujita K; Gonzalez FJ; Kamataki T
Cancer Res; 1998 May; 58(9):1833-8. PubMed ID: 9581821
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of CHO repair-proficient cell lines for comparative mutagenicity and metabolism of heterocyclic amines from cooked food.
Wu RW; Panteleakos FN; Felton JS
Environ Mol Mutagen; 2003; 41(1):7-13. PubMed ID: 12552587
[TBL] [Abstract][Full Text] [Related]
15. Activation and detoxication of carcinogenic arylamines by sulfation.
Yamazoe Y; Nagata K; Ozawa S; Gong DW; Kato R
Princess Takamatsu Symp; 1995; 23():154-62. PubMed ID: 8844806
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the antimutagenic potential of anthracene: in vitro and ex vivo studies.
Bu-Abbas A; Ioannides C; Walker R
Mutat Res; 1994 Aug; 309(1):101-7. PubMed ID: 7519726
[TBL] [Abstract][Full Text] [Related]
17. Short-term black tea intake modulates the excretion of urinary mutagens in rats treated with 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ): role of CYP1A2 upregulation.
Yoxall VR; Parker DA; Kentish PA; Ioannides C
Arch Toxicol; 2004 Aug; 78(8):477-82. PubMed ID: 15034640
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P4501A2 constitutively expressed from transduced DNA mediates metabolic activation and DNA-adduct formation of aromatic amine carcinogens in NIH 3T3 cells.
Battula N; Schut HA; Thorgeirsson SS
Mol Carcinog; 1991; 4(5):407-14. PubMed ID: 1910484
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin-H synthase mediated metabolism and mutagenic activation of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ).
Wolz E; Wild D; Degen GH
Arch Toxicol; 1995; 69(3):171-9. PubMed ID: 7717873
[TBL] [Abstract][Full Text] [Related]
20. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
